The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function Article Report uri icon

Overview

MeSH Major

  • Intestine, Small

abstract

  • A strategy combining sirolimus with basiliximab for low-immunologic risk recipients and thymoglobulin for high-risk recipients leads to prompt recovery of renal function with a low risk of acute rejection episodes.

publication date

  • September 27, 2004

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1097/01.TP.0000134399.10352.E4

PubMed ID

  • 15385812

Additional Document Info

start page

  • 904

end page

  • 10

volume

  • 78

number

  • 6